Establishment Labs’ (ESTA) “Overweight” Rating Reiterated at Stephens

Stephens reaffirmed their overweight rating on shares of Establishment Labs (NASDAQ:ESTA) in a research note released on Thursday,Benzinga reports. Stephens currently has a $52.00 price objective on the stock.

Establishment Labs Stock Performance

Shares of Establishment Labs stock opened at $42.87 on Thursday. The business’s fifty day simple moving average is $37.50 and its 200 day simple moving average is $41.35. The firm has a market capitalization of $1.20 billion, a P/E ratio of -16.62 and a beta of 1.12. Establishment Labs has a 12 month low of $28.16 and a 12 month high of $60.12. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94.

Establishment Labs (NASDAQ:ESTA) last issued its earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by ($0.34). The firm had revenue of $44.51 million during the quarter, compared to the consensus estimate of $44.45 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. As a group, analysts anticipate that Establishment Labs will post -2.41 EPS for the current year.

Institutional Trading of Establishment Labs

Several hedge funds have recently made changes to their positions in the company. Brown Advisory Inc. raised its stake in shares of Establishment Labs by 23.1% in the fourth quarter. Brown Advisory Inc. now owns 2,338,369 shares of the company’s stock valued at $107,729,000 after buying an additional 438,057 shares during the period. Capital Research Global Investors raised its stake in shares of Establishment Labs by 29.3% in the fourth quarter. Capital Research Global Investors now owns 1,911,525 shares of the company’s stock valued at $88,064,000 after buying an additional 433,484 shares during the period. Findell Capital Management LLC raised its stake in shares of Establishment Labs by 28.5% in the fourth quarter. Findell Capital Management LLC now owns 1,346,480 shares of the company’s stock valued at $62,032,000 after buying an additional 298,380 shares during the period. William Blair Investment Management LLC raised its stake in shares of Establishment Labs by 44.1% during the 4th quarter. William Blair Investment Management LLC now owns 812,825 shares of the company’s stock valued at $37,447,000 after purchasing an additional 248,888 shares during the period. Finally, Rice Hall James & Associates LLC raised its stake in shares of Establishment Labs by 10.7% during the 3rd quarter. Rice Hall James & Associates LLC now owns 793,300 shares of the company’s stock valued at $34,326,000 after purchasing an additional 76,959 shares during the period. 72.91% of the stock is currently owned by institutional investors.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.